These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12682267)

  • 1. A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice.
    Inal JM; Schneider B; Armanini M; Schifferli JA
    J Immunol; 2003 Apr; 170(8):4310-7. PubMed ID: 12682267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
    Hui KM; Magnadóttir B; Schifferli JA; Inal JM
    Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2.
    Inal JM; Sim RB
    FEBS Lett; 2000 Mar; 470(2):131-4. PubMed ID: 10734221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.
    Strachan AJ; Woodruff TM; Haaima G; Fairlie DP; Taylor SM
    J Immunol; 2000 Jun; 164(12):6560-5. PubMed ID: 10843715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor.
    Inal JM; Hui KM; Miot S; Lange S; Ramirez MI; Schneider B; Krueger G; Schifferli JA
    J Immunol; 2005 Jan; 174(1):356-66. PubMed ID: 15611259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.
    Oh KS; Kweon MH; Rhee KH; Ho Lee K; Sung HC
    Immunology; 2003 Sep; 110(1):73-9. PubMed ID: 12941143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
    Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
    Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats.
    Yeh CG; Marsh HC; Carson GR; Berman L; Concino MF; Scesney SM; Kuestner RE; Skibbens R; Donahue KA; Ip SH
    J Immunol; 1991 Jan; 146(1):250-6. PubMed ID: 1824590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
    Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
    J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C2 receptor inhibitor trispanning: from man to schistosome.
    Inal JM
    Springer Semin Immunopathol; 2005 Nov; 27(3):320-31. PubMed ID: 16235057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
    Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
    J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi.
    Cestari Idos S; Evans-Osses I; Freitas JC; Inal JM; Ramirez MI
    J Infect Dis; 2008 Nov; 198(9):1276-83. PubMed ID: 18781865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arthus reaction in rodents: species-specific requirement of complement.
    Szalai AJ; Digerness SB; Agrawal A; Kearney JF; Bucy RP; Niwas S; Kilpatrick JM; Babu YS; Volanakis JE
    J Immunol; 2000 Jan; 164(1):463-8. PubMed ID: 10605043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis.
    Inal J; Miot S; Schifferli JA
    Exp Cell Res; 2005 Oct; 310(1):54-65. PubMed ID: 16112669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression.
    Kaburagi Y; Hasegawa M; Nagaoka T; Shimada Y; Hamaguchi Y; Komura K; Saito E; Yanaba K; Takehara K; Kadono T; Steeber DA; Tedder TF; Sato S
    J Immunol; 2002 Mar; 168(6):2970-8. PubMed ID: 11884469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for Vav proteins in post-recruitment neutrophil cytotoxicity in IgG but not complement C3-dependent injury.
    Utomo A; Hirahashi J; Mekala D; Asano K; Glogauer M; Cullere X; Mayadas TN
    J Immunol; 2008 May; 180(9):6279-87. PubMed ID: 18424751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction.
    Santos LL; Huang XR; Berndt MC; Holdsworth SR
    Clin Exp Immunol; 1998 May; 112(2):281-6. PubMed ID: 9649192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.